MedTrace Logo

HERO Study: Helping Evaluate Reduction in Obesity

NCT00953173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 671

Last updated 2018-03-08

Study results available
· View outcomes & findings →

Summary

A prospective, international, multi-center study of clinical outcomes and estimated healthcare resource expenditures associated with the treatment of obesity using the LAP-BAND AP® Adjustable Gastric Banding System.

Conditions

Interventions

DEVICE

LAP-BAND AP® Adjustable Gastric Banding System

The LAP-BAND AP® is a device surgically implanted via a laparoscopic procedure. It is designed to induce weight loss in severely obese patients by limiting food consumption.

Sponsors & Collaborators

  • Apollo Endosurgery, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2016-07-31
Completion
2016-10-31

Countries

  • United States
  • Australia
  • Belgium
  • Canada
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00953173 on ClinicalTrials.gov